140 related articles for article (PubMed ID: 35876752)
21. The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas.
Skálová A; Stenman G; Simpson RHW; Hellquist H; Slouka D; Svoboda T; Bishop JA; Hunt JL; Nibu KI; Rinaldo A; Vander Poorten V; Devaney KO; Steiner P; Ferlito A
Am J Surg Pathol; 2018 Feb; 42(2):e11-e27. PubMed ID: 29076877
[TBL] [Abstract][Full Text] [Related]
22. Targeted molecular profiling of salivary duct carcinoma with rhabdoid features highlights parallels to other apocrine and discohesive neoplasms: which phenotype should drive classification?
Rooper LM; Gagan J; Bishop JA
Head Neck Pathol; 2022 Dec; 16(4):1063-1072. PubMed ID: 35794510
[TBL] [Abstract][Full Text] [Related]
23. Oncocytic mucoepidermoid carcinoma of the parotid gland with CRTC1-MAML2 fusion transcript: report of a case with review of literature.
Fujimaki M; Fukumura Y; Saito T; Mitani K; Uchida S; Yokoyama J; Yao T; Ikeda K
Hum Pathol; 2011 Dec; 42(12):2052-5. PubMed ID: 21676434
[TBL] [Abstract][Full Text] [Related]
24. Salivary duct carcinoma: Updates in histology, cytology, molecular biology, and treatment.
Nakaguro M; Tada Y; Faquin WC; Sadow PM; Wirth LJ; Nagao T
Cancer Cytopathol; 2020 Oct; 128(10):693-703. PubMed ID: 32421944
[TBL] [Abstract][Full Text] [Related]
25. A rare malignancy of the parotid gland: oncocytic carcinoma.
Guclu E; Oghan F; Ozturk O; Alper M; Egeli E
Eur Arch Otorhinolaryngol; 2005 Jul; 262(7):567-9. PubMed ID: 15592856
[TBL] [Abstract][Full Text] [Related]
26. Low-grade intraductal carcinoma of the salivary gland with prominent oncocytic change: a newly described variant.
Nakaguro M; Urano M; Suzuki H; Yamada K; Sakaguchi A; Ogura K; Matsumoto T; Ono N; Asato T; Mikami Y; Imai H; Nagao T
Histopathology; 2018 Aug; 73(2):314-320. PubMed ID: 29574881
[TBL] [Abstract][Full Text] [Related]
27. Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications.
Santana T; Pavel A; Martinek P; Steiner P; Grossmann P; Baněčková M; Skálová A
Hum Pathol; 2019 Nov; 93():37-47. PubMed ID: 31437521
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological study of intraductal carcinoma of the salivary gland, with emphasis on the apocrine type.
Hsieh MS; Lee YH; Jin YT; Kuo YJ
Virchows Arch; 2020 Oct; 477(4):581-592. PubMed ID: 32383006
[TBL] [Abstract][Full Text] [Related]
29. Adenomyoepitheliomas of the Breast Frequently Harbor Recurrent Hotspot Mutations in PIK3-AKT Pathway-related Genes and a Subset Show Genetic Similarity to Salivary Gland Epithelial-Myoepithelial Carcinoma.
Lubin D; Toorens E; Zhang PJ; Jaffer S; Baraban E; Bleiweiss IJ; Nayak A
Am J Surg Pathol; 2019 Jul; 43(7):1005-1013. PubMed ID: 31094929
[TBL] [Abstract][Full Text] [Related]
30. CDK12 alterations and ARID1A mutations are predictors of poor prognosis and therapeutic targets in high-grade salivary gland carcinoma: analysis of the National Genomic Profiling Database.
Kobayashi K; Saito Y; Kage H; Fukuoka O; Yamamura K; Mukai T; Oda K; Yamasoba T
Jpn J Clin Oncol; 2023 Aug; 53(9):798-807. PubMed ID: 37357968
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies.
Ross JS; Gay LM; Wang K; Vergilio JA; Suh J; Ramkissoon S; Somerset H; Johnson JM; Russell J; Ali S; Schrock AB; Fabrizio D; Frampton G; Miller V; Stephens PJ; Elvin JA; Bowles DW
Ann Oncol; 2017 Oct; 28(10):2539-2546. PubMed ID: 28961851
[TBL] [Abstract][Full Text] [Related]
32. ALK Rearrangements Characterize 2 Distinct Types of Salivary Gland Carcinomas: Clinicopathologic and Molecular Analysis of 4 Cases and Literature Review.
Agaimy A; Baněčková M; Ihrler S; Mueller SK; Franchi A; Hartmann A; Stoehr R; Skálová A
Am J Surg Pathol; 2021 Sep; 45(9):1166-1178. PubMed ID: 33871952
[TBL] [Abstract][Full Text] [Related]
33. Low-grade Apocrine Intraductal Carcinoma: Expanding the Morphologic and Molecular Spectrum of an Enigmatic Salivary Gland Tumor.
Bishop JA; Gagan J; Krane JF; Jo VY
Head Neck Pathol; 2020 Dec; 14(4):869-875. PubMed ID: 31989433
[TBL] [Abstract][Full Text] [Related]
34. Oncocytic lipoadenomatous tumours of salivary glands.
Casadei GP; Collina G; Salerno A; Canani FB; Dall'olio D; Lega S
Histopathology; 2012 Dec; 61(6):1225-7. PubMed ID: 22882731
[No Abstract] [Full Text] [Related]
35. Analysis of the risk of malignancy associated with the basaloid and oncocytic subtypes of the salivary gland neoplasm of unknown malignant potential (SUMP) category in the Milan system.
Manucha V; Gonzalez MF; Akhtar I
Cancer Cytopathol; 2021 Aug; 129(8):603-611. PubMed ID: 33788998
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic Study of Sialadenoma Papilliferum of the Minor Salivary Glands: A Series of 8 New Cases With BRAF V600E Mutation-specific Immunohistochemical Analysis.
Owosho AA; Shasteen AM; Aguirre SE; Summersgill KF
Int J Surg Pathol; 2023 Oct; 31(7):1265-1272. PubMed ID: 36632022
[No Abstract] [Full Text] [Related]
37. Top Ten Oncocytic Head and Neck Lesions to Contemplate.
Bullock MJ; Jiang XS
Head Neck Pathol; 2023 Mar; 17(1):53-65. PubMed ID: 36928735
[TBL] [Abstract][Full Text] [Related]
38. Sclerosing Polycystic "Adenosis" of Salivary Glands: A Neoplasm Characterized by PI3K Pathway Alterations More Correctly Named Sclerosing Polycystic Adenoma.
Bishop JA; Gagan J; Baumhoer D; McLean-Holden AL; Oliai BR; Couce M; Thompson LDR
Head Neck Pathol; 2020 Sep; 14(3):630-636. PubMed ID: 31605313
[TBL] [Abstract][Full Text] [Related]
39. Oncocytic carcinoma of the salivary glands: A Danish national study.
Westergaard-Nielsen M; Godballe C; Andersen LJ; Primdahl H; Kristensen CA; Andersen E; Bjørndal K
Auris Nasus Larynx; 2018 Aug; 45(4):825-830. PubMed ID: 29100750
[TBL] [Abstract][Full Text] [Related]
40. Risk of malignancy associated with cytomorphology subtypes in the salivary gland neoplasm of uncertain malignant potential (SUMP) category in the Milan System: A bi-institutional study.
Chowsilpa S; An D; Lose H; Huang X; Nayar R; Maleki Z
Cancer Cytopathol; 2019 Jun; 127(6):377-389. PubMed ID: 31116514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
